Reportlinker.com

Reportlinker.com

March 27, 2008 06:02 ET

High Growth Forecasted for the World Nuclear Medicine Market

LONDON, UNITED KINGDOM--(Marketwire - March 27, 2008) - Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.

World Nuclear Medicine Market

This report analyzes the worldwide markets for Nuclear Medicine in Millions of US$. The specific product segments analyzed are Gamma Cameras, and PET Scanners. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 65 companies including many key and niche players worldwide such as Digirad Corporation, GE Healthcare Plc, Mallinckrodt, Inc., Molypharma S.A., Orbotech Medical Solutions Ltd, Philips Medical Systems, Inc., Positron Corporation, IS2 Medical Systems, Siemens Medical Solutions USA, Inc., Toshiba Medical Systems Corporation, and Toshiba America Medical Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-2

Product Definitions and Scope of Study I-3

Gamma Cameras I-3

PET Scanners I-3

II. EXECUTIVE SUMMARY

1. Industry Overview and Outlook II-1

Market Snapshots II-1

Outlook II-2

Trends and Issues II-2

Market Shifts to Hybrid Imaging II-2

PET Makes Inroads into Conventional Gamma Camera Market II-2

Diagnostic Imaging Witnesses Dramatic Growth II-2

Aging Population and Healthy Reimbursement Drive Procedure Volumes II-3

Volumes II-3

Technology Innovations Promise Bright Prospects II-3

Competition II-3

Table 1: Leading Players in the Global Gamma Camera Market (2006 & 2007): Percentage Breakdown of Value Sales for Philips Medical Systems, Siemens Medical Solutions, GE Healthcare, and Others (includes corresponding Graph/Chart) II-4

Table 2: Leading Players in the Global PET Scanner Market (2006 & 2007): Percentage Breakdown of Value Sales for Siemens Medical Solutions, GE Healthcare, Philips Medical Systems, and Others (includes corresponding Graph/Chart) II-4

Leading Players in the Worldwide Nuclear Medicine Market: A Completive Analysis II-5

Nuclear Medicine Market - Key Statistics II-6

Table 3: Global Gamma Cameras Market (2005): Installed Based in Units by Select Country - USA, Japan, Canada, and UK (includes corresponding Graph/Chart) II-6

Table 4: Global PET Scanners Market (2005): Installed Base in Units by Select Country - USA, Europe, Japan, Germany, Canada, UK, France, Italy, and Belgium (includes corresponding Graph/Chart) II-6

Estimated Prices of Nuclear Medicine Systems II-6

2. Nuclear Medicine - An Insight II-7

Distinct from General Radiology II-7

History II-7

Major Developments II-8

Nuclear Medicine Scans II-8

Bone Scan II-9

Brain Scan II-9

Gallbladder Scan II-9

Kidney Scan II-10

Liver Scan II-10

Lung Scan II-10

Thyroid Scan II-10

Scrotal Scan II-10

Applications II-11

Cardiac Applications II-11

Neurologic Applications II-11

Oncologic Applications II-11

Orthopedic Applications II-11

Pulmonary Applications II-12

Renal Applications II-12

Other Applications II-12

Estimated Time Allocations for Nuclear Medicine Procedures II-12

Radioisotopes: Essential for Nuclear Medicine Procedure II-13

Radioisotopes Used in Medicine II-13

Clinical Applications of Select Isotopes II-15

Radionuclides in Nuclear Medicine Procedures II-16

Positron-Emitting Radionuclides in PET Procedures II-16

3. Nuclear Medicine Imaging Equipment II-17

Gamma Cameras II-17

Positron Emission Tomography (PET) Scanners II-17

Factors Influencing Growth of PET Scanners II-18

PET & Other Imaging Modalities II-18

Table 5: Comparison of PET and Conventional Imaging Techniques (includes corresponding Graph/Chart) II-19

Brain Imaging II-19

Alzheimer's Disease II-19

Brain Trauma II-20

Epilepsy II-20

Heart Imaging II-20

Mobile PET II-20

Parkinson's Disease II-20

PET & Cancer II-20

PET-CT: An Advancement in Cancer Diagnosis & Treatment II-21

4. Research and Development II-22

Philips and University Medical Center Hamburg- Eppendorf Develop MRI/PET Imaging Tool II-22

Indian Scientists Develop Low-Cost Nuclear Medicine Kit II-22

5. Product Innovations/Introductions II-23

Philips Launches MOSAIC HP Imaging System II-23

Digirad Launches nSPEEDsm II-23

Philips Introduces PET/CT Pulmonary Toolkit II-23

Siemens to Introduce New High Definition PET-CT II-23

Philips Extends Availability of PET/CT Viewer to iSite PACS Settings II-23

Philips Announces Commercial Availability of JETStream Workspace 3.0 II-24

Philips Launches NanoSPECT/CT II-24

Philips Announces Improvements to GEMINI TF PET/CT System II-24

Philips Launches New Portfolio of Sophisticated Hybrid-Imaging Technologies II-24

Siemens Launches Novel Range of PET-CT Systems II-25

Philips Debuts BrightView SPECT System II-25

Digirad Unveils Triple-Head, Cardius3 Xpo Camera II-25

GE Healthcare Introduces Xeleris 2 Nuclear Medicine Workstation II-25

Gamma-Medica Ideas Launch New Pre-Clinical Imaging Equipment II-25

Naviscan PET Systems Introduces PEM Flex(TM) Solo II II-26

TeraRecon Launches Mini Gamma Camera II-26

Digirad Unveils Cardius-3 Gamma Camera II-26

Siemens Medical Solutions Adds New Feature to c.cam Dedicated Cardiac Gamma Camera II-26

Siemens Launches Symbia S SPECT System II-26

GE Healthcare Introduces Discovery STE PET/CT Imaging System II-27

GE Healthcare Debuts PETtrace 10 Cyclotron for PET Radioisotope Production II-27

MedImage Adds NeuroQ Software Feature to MedView II-27

Philips Introduces Gemini GXL PET/CT System II-27

Digirad Unveils Cardius-1M Mobile Gamma Camera II-27

Philips Launches Philips Precedence SPECT/CT System II-27

Siemens Offers Biograph PET/CT System II-27

Digirad Launches Cardius-3 Imager II-28

Siemens Launches New PET/CT Scanners II-28

Digirad Introduces Cardius(TM)-1 Single-Head Gamma Camera II-28

GE Unveils Discovery LS16 PET/CT Scanner II-28

Digirad Upgrades Existing Product Line II-28

New PET Scanner Systems from Leading Manufacturers II-29

GE Develops eNTEGRA Workstation II-29

Advanced ECAT(R) ACCEL(TM) Scanner from Siemens II-29

Nuclear Medicine Group Rolls Out e.cam duet(TM) Dual Purpose Gamma Camera II-29

Digirad Unveils 2020tc Imager(TM) II-30

Bicron Develops Crystal Technology for Use with Gamma Cameras II-30

Asiawired Group Unveils World's First Solid-State Gamma Camera II-30

6. Recent Industry Activity II-31

Orbotech to Acquire Danish Diagnostic Development II-31

Covidien Imaging Solution Signs Agreement with BioSynthema II-31

Digirad Takes Over Ultrascan II-31

Triad Isotopes Acquires Three Major Nuclear Pharmacies II-31

International Isotopes Acquires Stake in RadQual II-32

Teleradiology and National Healthcare Group Enter into Joint Venture II-32

Philips and Bioscan Sign Marketing Agreement II-32

Mubadala Signs Contract with Siemens II-32

HealthCare Global and GE Healthcare Establish Advanced Molecular Imaging Center II-32

International Atomic Energy Agency Establishes Gamma Camera Laboratory II-33

Fujifilm Acquires Daiichi II-33

Positron Purchases IS2 Medical Systems II-33

Positron Corporation Partners with MIMvista II-33

Positron and Neusoft Medical Commence Joint Venture Company II-34

Idaho National Laboratory and NorthStar Ink Technology Agreements II-34

Amerinet and Medi/Nuclear Corporation Ink Three-Year Contract II-34

Daxor Inks Agreement with a Medical Center for BVA 100 Trials II-34

Dilon Technologies Inks Distribution Agreement with Hongwoo Medico II-34

Digirad Inks Agreement with Ultrascan II-35

NorthStar Inks Global Licensing Agreement for Radioisotope Advancement II-35

Positron Receives Approval for PET Device Usage II-35

GE Healthcare Commissions Integrated Development Center II-35

GE Healthcare to Establish Radiopharmacy Center II-36

Eko and Apollo to Establish Nuclear Medicine Center II-36

Vietnam to Establish Nuclear Medicine Center II-36

Pakistan to Establish New Nuclear Medicine Centers II-36

Siemens Acquires CTI Molecular Imaging II-36

Orbotech Acquires Imarad Imaging Systems II-37

GE Healthcare in Five-Year Partnership with Stanford's Department of Radiology II-37

Positron Inks Joint Venture with China's Neusoft Medical Systems II-37

Positron Receives Funding from Canada's Imagin Diagnostic Centers II-37

Mallinckrodt Secures Extension to Market NeutroSpec II-37

Indian Department of Atomic Energy Establishes HBNI II-37

Siemens Establishes Siemens Medical Solutions Molecular Imaging Division II-38

Royal Philips Secures Diagnostic Imaging Contract from HealthTrust Purchasing Group II-38

Bio-Imaging and Society of Nuclear Medicine Enter Alliance II-38

Rensselaer Receives Funding from National Institutes of Health II-38

GE Medical Systems Acquires Amersham II-38

Gamma Medica Extends Marketing Agreement with Siemens II-39

GE Medical Systems Extends Product Line II-39

Siemens Recalls General Purpose Gamma Camera Systems II-39

Philips Recalls Gamma Camera Systems II-39

GE Medical Systems Upgrades Infinia(TM) Hawkeye(R) II-39

Philips Recalls Prism 3000S and 3000XP Gamma Camera/Systems II-40

CPS Innovations Obtains Apparatus Patent from US Patent and Trademark Office II-40

Integral Nuclear Associates Enters into Agreement with Montefiore Medical Center II-40

First Oriental Nuclear Medicine Sets Up Fusion Scanners II-40

MedAssets Signs Agreement with Siemens II-40

Toshiba Launches e-commerce Site for Nuclear Medicine II-40

Digirad Receives Patents for Radiation Detectors and Gamma

Cameras II-41

CPS Obtains Market Clearance from FDA for LSO-Based PET/CT Scanner II-41

Philips Acquires Marconi Medical Systems II-41

Siemens Buys Equity Stake in Imarad Imaging Systems II-41

Philips Acquires ADAC Laboratories II-41

Mobile P.E.T. Systems Extends PET Scanner Product Line II-41

Digirad Receives Patents for Solid-State Digital Gamma Camera II-42

ADAC Laboratories Obtains Approval from US FDA II-42

7. Focus on Select Global Players II-43

Digirad Corporation (USA) II-43

GE Healthcare Plc (The United Kingdom) II-43

Mallinckrodt, Inc. (USA) II-43

Molypharma S.A. (Spain) II-43

Orbotech Medical Solutions Ltd. (Israel) II-43

Philips Medical Systems, Inc. (USA) II-44

Positron Corporation (USA) II-44

IS2 Medical Systems (Canada) II-44

Siemens Medical Solutions USA, Inc. (USA) II-44

Toshiba Medical Systems Corporation (Japan) II-45

Toshiba America Medical Systems, Inc. (USA) II-45

8. Global Market Perspective II-46

Table 6: World Recent Past, Current & Future Analysis for Nuclear Medicine by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-46

Table 7: World Long-term Projections for Nuclear Medicine by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-47

Table 8: World 11-Year Perspective for Nuclear Medicine by Geographic Region - Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for Years 2000, 2007, & 2010 (includes corresponding Graph/Chart) II-48

Table 9: World Recent Past, Current & Future Analysis for Gamma Cameras by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-49

Table 10: World Long-term Projections for Gamma Cameras by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-50

Table 11: World 11-Year Perspective for Gamma Cameras by Geographic Region - Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for Years 2000, 2007, & 2010 (includes corresponding Graph/Chart) II-51

Table 12: World Recent Past, Current & Future Analysis for PET Scanners by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-52

Table 13: World Long-term Projections for PET Scanners by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-53

Table 14: World 11-Year Perspective for PET Scanners by Geographic Region - Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia Pacific (excluding Japan), and Rest of World Markets for Years 2000, 2007, & 2010 (includes corresponding Graph/Chart) II-54

III. MARKET

1. The United States III-1

A.Market Analysis III-1

Current & Future Analysis III-1

Nuclear Medicine - Key Features III-1

Market Trends III-1

Nuclear Medicine Procedures on the Rise III-1

Table 15: Nuclear Medicine Market in the US (2000-2010): Procedures Performed Annually in Millions by Procedure Type - Cardiac and Non-Cardiac (includes corresponding Graph/Chart) III-2

Upsurge in Use of PET Scanners III-2

Gamma Cameras: Gaining a Niche in Cardiac Imaging III-2

Nuclear Cardiology: Primary Growth Propellant III-3

Shift Towards Hospital-based PET Procedures from Outpatient Facilities III-3

Growth in PET Procedure Volumes: Key Market Driver III-3

Table 16: Installed Base of PET Scanners in the US: 2000- 2005 (In Units) (includes corresponding Graph/Chart) III-4

Table 17: Installed Base of PET-CT Scanners in the US: 2000-2005 (In Units) (includes corresponding Graph/Chart) III-4

Table 18: PET Procedure Volumes in the US: 2000-2005 (In '000) (includes corresponding Graph/Chart) III-4

Table 19: PET-CT Procedure Volumes in the US: 2000-2005 (includes corresponding Graph/Chart) III-5

Reimbursement Scenario III-5

PET Scan Procedures Approved for Reimbursement III-5

Competition III-5

Gamma Cameras III-5

Table 20: Leading Players in the US Gamma Camera Market (2006 & 2007): Percentage Breakdown of Value Sales for Philips Medical Systems, Siemens Medical Solutions, GE Healthcare, and Others (includes corresponding Graph/Chart) III-6

Table 21: Leading Players in the US Cardiology Gamma Camera Market (2006 & 2007): Percentage Breakdown of Value Sales for Philips Medical, Digirad Corporation, GE Healthcare, and Siemens Medical (includes corresponding Graph/Chart) III-6

PET Scanners III-7

Table 22: Leading Players in the US PET Scanner Market (2006 & 2007): Percentage Breakdown of Value Sales for Siemens Medical Solutions, GE Healthcare, Philips Medical Systems, and Others (includes corresponding Graph/Chart) III-7

Regulatory Overview III-7

Nuclear Regulatory Commission (NRC) III-7

Food and Drug Administration (FDA) III-8

Environmental Protection Agency (EPA) III-8

Centers for Medicare & Medicaid Services (CMS) III-8

Product Launches/Developments III-8

Strategic Corporate Developments III-15

Key Players III-23

Digirad Corporation III-23

Mallinckrodt, Inc. III-23

Philips Medical Systems, Inc. III-23

Positron Corporation III-23

Siemens Medical Solutions USA, Inc. III-24

Toshiba America Medical Systems, Inc. III-24

B.Market Analytics III-24

Table 23: US Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in Units for Years 2000 through 2010 (includes corresponding Graph/Chart) III-24

Table 24: US Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in Units for Years 2011 through 2015 (includes corresponding Graph/Chart) III-25

Table 25: US 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Volume Sales for Gamma Cameras and PET Scanner Markets for Years 2000, 2007, & 2010 III-25

Table 26: US Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-26

Table 27: US Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-26

Table 28: US 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 (includes corresponding Graph/Chart) III-27

2. Canada III-28

A.Market Analysis III-28

Current & Future Analysis III-28

Canada Faces Serious Issue over Paucity of PET Scanners III-28

Table 29: PET Scanners and Gamma Cameras Market in Canada (2005): Installed Base in Units III-28

Table 30: Canadian Nuclear Medicine Market (2003-2005): Number of Cameras Per Million Population (includes corresponding Graph/Chart) III-28

Strategic Corporate Developments III-29

Key Player III-29

IS2 Medical Systems III-29

B.Market Analytics III-30

Table 31: Canadian Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-30

Table 32: Canadian Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-30

Table 33: Canadian 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-31

3. Japan III-32

A.Market Analysis III-32

Current & Future Analysis III-32

Market Scenario III-32

Table 34: PET Scanners and Gamma Cameras Market in Japan (2005): Installed Base in Units III-32

Table 35: PET Studies Performed in Japan (2002): Percentage Breakdown by Type - Tumor, Brain, Heart, and Others (includes corresponding Graph/Chart) III-33

Table 36: Gamma Cameras Availability in Japan (2002): Percentage Breakdown by Type - Single Head, Dual Head, Triple Head, Quadruple Head, and Ring Type (includes corresponding Graph/Chart) III-33

Strategic Corporate Development III-33

Key Player III-33

Toshiba Medical Systems Corporation III-33

B.Market Analytics III-34

Table 37: Japanese Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-34

Table 38: Japanese Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-35

Table 39: Japanese 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-35

4. Europe III-36

A.Market Analysis III-36

Current & Future Analysis III-36

Market Overview III-36

Table 40: PET Scanners Market in Europe (2005): Installed Base in units by Select Region - Europe, Germany, UK, France, Italy, and Belgium (includes corresponding Graph/Chart) III-36

Factors Driving European Gamma Camera Market III-37

European Diagnostic Imaging Market III-37

Strategic Corporate Developments III-37

B.Market Analytics III-38

Table 41: European Recent Past, Current & Future Analysis for Nuclear Medicine by Geographic Region - France, Germany, UK, Italy, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-38

Table 42: European Long-term Projections for Nuclear Medicine by Geographic Region - France, Germany, UK, Italy, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-38

Table 43: European Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras (Single Head, Dual Head, and Triple Head Cameras) and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-39

Table 44: European Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras (Single Head, Dual Head, and Triple Head Cameras) and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-39

Table 45: European 11-Year Perspective for Nuclear Medicine by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, and Rest of Europe Markets for Years 2000, 2007, & 2010 (includes corresponding Graph/Chart) III-40

Table 46: European 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras (Single Head, Dual Head, and Triple Head Cameras), and PET Scanners Markets for Years 2000, 2007, & 2010 (includes corresponding Graph/Chart) III-40

4a. France III-41

Market Overview III-41

Current & Future Analysis III-41

Table 47: French Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-41

Table 48: French Long-term Proojections for Nuclear Medicin by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-42

Table 49: French 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-42

4b. Germany III-43

Market Overview III-43

Current & Future Analysis III-43

Table 50: German Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-43

Table 51: German Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-44

Table 52: German 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-44

4c. The United Kingdom III-45

A.Market Analysis III-45

Current & Future Analysis III-45

Market Overview III-45

Gamma Cameras III-45

Table 53: Nuclear Medicine Market in the UK (2004): Percentage Breakdown of Sales by Technology - Planar Imaging, SPECT, PET, Non-Diagnostic Imaging, and Therapy (includes corresponding Graph/Chart) III-45

Table 54: Leading Players in the UK Gamma Camera Market (2004): Percentage Breakdown of Number of Gamma Cameras in Use for GE Healthcare, Philips Medical, Siemens Medical, Toshiba, and Others (includes corresponding Graph/Chart) III-46

PET Scanners III-46

Table 55: Gamma Cameras and PET Scanners Market in the UK (2005): Installed Base in Units III-46

Key Player III-46

GE Healthcare Plc III-46

B.Market Analytics III-47

Table 56: UK Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-47

Table 57: UK Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-47

Table 58: UK 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-48

4d. Italy III-49

Market Overview III-49

Current & Future Analysis III-49

Table 59: Italian Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-49

Table 60: Italian Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-50

Table 61: Italian 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-50

4e. Spain III-51

A.Market Analysis III-51

Current & Future Analysis III-51

Key Player III-51

Molypharma S.A. III-51

B.Market Analytics III-51

Table 62: Spanish Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-51

Table 63: Spanish Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-52

Table 64: Spanish 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-52

4f. Rest of Europe III-53

A. Market Overview III-53

Current & Future Analysis III-53

Strategic Corporate Development III-53

B.Market Analytics III-54

Table 65: Rest of Europe Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-54

Table 66: Rest of Europe Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-54

Table 67: Rest of Europe 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-55

5. Asia-Pacific III-56

A.Market Analysis III-56

Current & Future Analysis III-56

Market Overview III-56

Focus on Select Markets III-56

China III-56

Korea III-56

Strategic Corporate Developments III-57

B.Market Analytics III-59

Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-59

Table 69: Asia-Pacific Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-60

Table 70: Asia-Pacific 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-60

6. Rest of World III-61

A.Market Analysis III-61

Current & Future Analysis III-61

Focus on Select Markets III-61

The Middle East III-61

Latin America III-61

Strategic Corporate Developments III-61

Key Player III-62

Orbotech Medical Solutions Ltd. (Israel) III-62

B.Market Analytics III-62

Table 71: Rest of World Recent Past, Current & Future Analysis for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-62

Table 72: Rest of World Long-term Projections for Nuclear Medicine by Product Segment - Gamma Cameras and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-63

Table 73: Rest of World 11-Year Perspective for Nuclear Medicine - Percentage Breakdown of Value Sales for Gamma Cameras and PET Scanners Markets for Years 2000, 2007, & 2010 III-63

IV. COMPETITIVE LANDSCAPE

To order this report:

World Nuclear Medicine Market

More market research reports here!

Contact Information